Drug-related infectious diseases key (DRID) indicator
Belgium
Bulgaria
Drug-related infectious diseases key epidemiological indicator
Drug-related infectious diseases (DRID)
This key indicator collects data on the extent of infectious diseases — primarily HIV, hepatitis C and hepatitis B infection — among people who inject drugs (injecting drug users or IDUs). The data is collected from IDUs each calendar year using two main methods. These are: (a) surveys of IDUs that include serological testing and (b) the monitoring of routine diagnostic testing for HIV, hepatitis C and hepatitis B infection among IDUs.
Read more »
Key methodological documents
DRID toolkit (November 2013)
The most recent work in DRID has resulted in a more flexible approach to DRID guidance, through a toolkit with modules and is principally aimed at professionals in the field. The first three modules were finalised in 2013 and cover:
- Behavioural indicators
A contextual complement to biological monitoring, covering risk and protective behaviours, testing, service uptake etc. - Example questionnaire
More detailed questions as applicable in national studies, including those that are needed to construct the behavioural indicators - Methods of bio-behavioural studies
Provides a short overview of methods and issues with regard to setting up monitoring through repeated studies in people who inject drugs
Reported data
The data collected through the PDU key indicator is published annually as part of the EMCDDA's Statistical bulletin. Direct links to the PDU data set for recent years can be found below:
- 2016 Drug-related infectious diseases statistics
- 2015 Drug-related infectious diseases statistics
- 2014 Drug-related infectious diseases statistics
- 2013 Drug-related infectious diseases statistics
- 2012 Drug-related infectious diseases statistics
- 2011 Drug-related infectious diseases statistics
- 2010 Drug-related infectious diseases statistics
- 2009 Drug-related infectious diseases statistics
- 2008 Drug-related infectious diseases statistics
Data is used in many EMCDDA products, including in the following key resoures:
Expert meetings
- Drug-related infectious diseases (DRID) key epidemiological indicator expert meeting, 6–8 June 2016, Lisbon
- Drug-related Diseases (DRID) key epidemiological indicators expert meetings, 15–16 June 2015, Lisbon
- Drug-related deaths (DRD) and Drug-related Diseases (DRID) key epidemiological indicators expert meetings, 15–17 October 2014, Lisbon
- Drug-related deaths (DRD) and Drug-related Diseases (DRID) key epidemiological indicators expert meetings, 16-18 October 2013, Lisbon
For the time being this is available in a password-restricted area, accessible to experts participating in the meetings and the national focal points and can be accessed here: password restrcited area.
About the EMCDDA
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>
Contact
The EMCDDA is located at:
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
